Evaluation of the Safety and Immunogenicity of the RTS,S/AS01 E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization

Autor: Agnandji, Selidji T., Asante, Kwaku Poku, Lyimo, John, Vekemans, Johan, Soulanoudjingar, Solange S., Owusu, Ruth, Shomari, Mwanajaa, Leach, Amanda, Fernandes, Jose, Dosoo, David, Chikawe, Maria, Issifou, Saadou, Osei-Kwakye, Kingsley, Lievens, Marc, Paricek, Maria, Apanga, Stephen, Mwangoka, Grace, Okissi, Blaise, Kwara, Evans, Minja, Rose, Lange, Jorn, Boahen, Owusu, Kayan, Kingsley, Adjei, George, Chandramohan, Daniel, Jongert, Erik, Demoitié, Marie-Ange, Dubois, Marie-Claude, Carter, Terrel, Vansadia, Preeti, Villafana, Tonya, Sillman, Marla, Savarese, Barbara, Lapierre, Didier, Ballou, William Ripley, Greenwood, Brian, Tanner, Marcel, Cohen, Joe, Kremsner, Peter G., Lell, Bertrand, Owusu-Agyei, Seth, Abdulla, Salim

Publikováno v: The Journal of Infectious Diseases, 2010 Oct 01. 202(7), 1076-1087.

Externí odkaz: https://www.jstor.org/stable/20780228

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Autor: RTS,S Clinical Trials Partnership, Agnandji, Selidji Todagbe, Lell, Bertrand, Fernandes, José Francisco, Abossolo, Béatrice Peggy, Methogo, Barbara Gaelle Nfono Ondo, Kabwende, Anita Lumeka, Adegnika, Ayola Akim, Mordmüller, Benjamin, Issifou, Saadou, Kremsner, Peter Gottfried, Sacarlal, Jahit, Aide, Pedro, Lanaspa, Miguel, Aponte, John J, Machevo, Sonia, Acacio, Sozinho, Bulo, Helder, Sigauque, Betuel, Macete, Eusébio, Alonso, Pedro, Abdulla, Salim, Salim, Nahya, Minja, Rose, Mpina, Maxmillian, Ahmed, Saumu, Ali, Ali Mohammed, Mtoro, Ali Takadir, Hamad, Ali Said, Mutani, Paul, Tanner, Marcel, Tinto, Halidou, D'Alessandro, Umberto, Sorgho, Hermann, Valea, Innocent, Bihoun, Biébo, Guiraud, Issa, Kaboré, Berenger, Sombié, Olivier, Guiguemdé, Robert Tinga, Ouédraogo, Jean Bosco, Hamel, Mary J, Kariuki, Simon, Oneko, Martina, Odero, Chris, Otieno, Kephas, Awino, Norbert, McMorrow, Meredith, Muturi-Kioi, Vincent, Laserson, Kayla F, Slutsker, Laurence, Otieno, Walter, Otieno, Lucas, Otsyula, Nekoye, Gondi, Stacey, Otieno, Allan, Owira, Victorine, Oguk, Esther, Odongo, George, Woods, Jon Ben, Ogutu, Bernhards, Njuguna, Patricia, Chilengi, Roma, Akoo, Pauline, Kerubo, Christine, Maingi, Charity, Lang, Trudie, Olotu, Ally, Bejon, Philip, Marsh, Kevin, Mwambingu, Gabriel, Owusu-Agyei, Seth, Asante, Kwaku Poku, Osei-Kwakye, Kingsley, Boahen, Owusu, Dosoo, David, Asante, Isaac, Adjei, George, Kwara, Evans, Chandramohan, Daniel, Greenwood, Brian, Lusingu, John, Gesase, Samwel, Malabeja, Anangisye, Abdul, Omari, Mahende, Coline, Liheluka, Edwin, Malle, Lincoln, Lemnge, Martha, Theander, Thor G, Drakeley, Chris, Ansong, Daniel, Agbenyega, Tsiri, Adjei, Samuel, Boateng, Harry Owusu, Rettig, Theresa, Bawa, John, Sylverken, Justice, Sambian, David, Sarfo, Anima, Agyekum, Alex, Martinson, Francis, Hoffman, Irving, Mvalo, Tisungane, Kamthunzi, Portia, Nkomo, Rutendo, Tembo, Tapiwa, Tegha, Gerald, Tsidya, Mercy, Kilembe, Jane, Chawinga, Chimwemwe, Ballou, W Ripley, Cohen, Joe, Guerra, Yolanda, Jongert, Erik, Lapierre, Didier, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Olivier, Aurélie, Vekemans, Johan, Carter, Terrell, Kaslow, David, Leboulleux, Didier, Loucq, Christian, Radford, Afiya, Savarese, Barbara, Schellenberg, David, Sillman, Marla, Vansadia, Preeti

BACKGROUND: The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe malaria in children 5 to 17 months of age by approximately 50% in an ongoing phase 3 trial. We studied infants 6 to 12 weeks of age recruited for the sa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::627444d217862e9c4174a586ebbeb0b8
https://researchonline.lshtm.ac.uk/id/eprint/427472/1/nejmoa1208394.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation of the Safety and Immunogenicity of the RTS,S/ASO1E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization.

Autor: Agnandji, Selidji T., Asante, Kwaku Poku, Lyimo, John, Vekemans, Johan, Souianoudjingar, Solange S., Owusu, Ruth, Shomari, Mwanajaa, Leach, Amanda, Fernandes, Jose, Dosoo, David, Chikawe, Maria, lssifou, Saadou, Osei-Kwakye, Kingsley, Lievens, Marc, Paricek, Maria, Apanga, Stephen, Mwangoka, Grace, Okissi, Blaise, Kwara, Evans, Minja, Rose

Publikováno v: Journal of Infectious Diseases; 10/1/2010, Vol. 202 Issue 7, p1076-1087, 12p